Core Points - Aimfinity Investment Corp. I (AIMA) will be delisted from Nasdaq and will begin trading on OTC Markets under new tickers on May 5, 2025 [1] - AIMA's business combination with Docter Inc. remains on track despite the venue change, with both parties committed to securing Nasdaq listing approval for the combined entity [2] - AIMA has extended the deadline to complete the business combination to May 28, 2025, by depositing $55,823.80 into its trust account [3][4] Company Information - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) focused on merging with high-growth potential businesses [5] - Docter Inc. is a health technology company that develops innovative health monitoring solutions to improve global healthcare accessibility and efficiency [6] Transaction Details - AIMA entered into a merger agreement with Docter on October 13, 2023, involving a reincorporation merger and an acquisition merger [7] - The proxy statement/prospectus related to the proposed business combination has been mailed to AIMA's shareholders as of February 25, 2025 [12]
Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination